Literature DB >> 22847371

Effects of EG-VEGF, VEGF and TGF-β1 on pregnancy outcome in patients undergoing IVF-ET treatment.

Min-zhi Gao1, Xiao-ming Zhao, Yi Lin, Zhao-gui Sun, Hui-qin Zhang.   

Abstract

PURPOSE: To investigate the correlation of endocrine gland-derived vascular endothelial growth factor (EG-VEGF), vascular endothelial growth factor (VEGF) and transforming growth factor beta 1 (TGF-β1) with the corresponding reproductive outcome in patients who received in vitro fertilization-embryo transfer (IVF-ET).
METHODS: Sixty-seven women undergoing IVF-ET at a university tertiary hospital were recruited for a prospective study. Concentrations of EG-VEGF, VEGF and TGF-β1 were measured by enzyme-linked immunosorbent assay (ELISA) in follicular fluid (FF) collected during oocyte retrieval (OR) and in serum collected 2 days after OR.
RESULTS: In FF, concentrations of both EG-VEGF and VEGF were negatively correlated with peak E2 and the number of MII oocytes retrieved, and positively correlated with each other. In serum, concentrations of all the three growth factors were positively correlated with the rate of good quality embryo, and with one another. Patients in the pregnancy group had lower peak E2 concentrations and higher serum EG-VEGF concentrations than those in the non-pregnancy group, but such tendency was not observed in the case of VEGF and TGF-β1.
CONCLUSIONS: Both concentrations of EG-VEGF and VEGF in FF were negatively correlated with ovarian response and oocyte maturation. Concentrations of all the three growth factors in serum were positively correlated with embryo quality, but only serum concentrations of EG-VEGF were associated with the pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847371      PMCID: PMC3492577          DOI: 10.1007/s10815-012-9833-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  27 in total

1.  Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy.

Authors:  N Sugino; S Kashida; A Karube-Harada; S Takiguchi; H Kato
Journal:  Reproduction       Date:  2002-03       Impact factor: 3.906

2.  Increase in transforming growth factor beta1 in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy.

Authors:  G Fried; H Wramsby
Journal:  Hum Reprod       Date:  1998-03       Impact factor: 6.918

3.  No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program.

Authors:  L Unkila-Kallio; P Vuorela-Vepsäläinen; A Tiitinen; E Halmesmäki; O Ylikorkala
Journal:  Am J Reprod Immunol       Date:  2000-01       Impact factor: 3.886

4.  Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.

Authors:  Min-Zhi Gao; Xiao-Ming Zhao; Zhao-Gui Sun; Yan Hong; Lei-Wen Zhao; Hui-Qin Zhang
Journal:  Fertil Steril       Date:  2010-11-10       Impact factor: 7.329

5.  Chorioallantoic placenta formation in the rat: II. Angiogenesis and maternal blood circulation in the mesometrial region of the implantation chamber prior to placenta formation.

Authors:  A O Welsh; A C Enders
Journal:  Am J Anat       Date:  1991-12

6.  Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells.

Authors:  Tatiana Kisliouk; Nitzan Levy; Arye Hurwitz; Rina Meidan
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

7.  Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential.

Authors:  C I Friedman; D B Seifer; E A Kennard; L Arbogast; B Alak; D R Danforth
Journal:  Fertil Steril       Date:  1998-11       Impact factor: 7.329

8.  Ovarian response of individuals to different doses of human menopausal gonadotropin.

Authors:  C A Benadiva; Z Ben-Rafael; J F Strauss; L Mastroianni; G L Flickinger
Journal:  Fertil Steril       Date:  1988-06       Impact factor: 7.329

9.  Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA.

Authors:  G W Mulheron; N L Bossert; J A Lapp; D K Walmer; D W Schomberg
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

Review 10.  EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors.

Authors:  Napoleone Ferrara; Jennifer LeCouter; Rui Lin; Franklin Peale
Journal:  Biochim Biophys Acta       Date:  2004-03-04
View more
  4 in total

1.  Intrafollicular interleukin-8, interleukin-12, and adrenomedullin are the promising prognostic markers of oocyte and embryo quality in women with endometriosis.

Authors:  Abhay Kumar Singh; Mainak Dutta; Ratna Chattopadhyay; Baidyanath Chakravarty; Koel Chaudhury
Journal:  J Assist Reprod Genet       Date:  2016-08-05       Impact factor: 3.412

2.  Perifollicular blood flow and its relationship with endometrial vascularity, follicular fluid EG-VEGF, IGF-1, and inhibin-a levels and IVF outcomes.

Authors:  Fisun Vural; Birol Vural; Emek Doğer; Yiğit Çakıroğlu; Mustafa Çekmen
Journal:  J Assist Reprod Genet       Date:  2016-08-02       Impact factor: 3.412

3.  ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes.

Authors:  Ju-Fen Zheng; Xiao-Bao Chen; Lei-Wen Zhao; Min-Zhi Gao; Jie Peng; Xian-Qin Qu; Hui-Juan Shi; Xing-Liang Jin
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

4.  The safety of intracytoplasmic sperm injection in men with hepatitis B.

Authors:  Zhong Zheng; Xiaoming Zhao; Yan Hong; Bing Xu; Jing Tong; Lan Xia
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.